Localisation of active TGF-β1 is observed in inflammatory- and tumour cells and especially in tumour-associated myofibroblasts, implying that increased levels of activated TGF-β1, more than overall TGF-β1 levels, are associated with accumulation of myofibroblasts in gastric cancer. The gene discussed is TGFB1; the disease is neoplasm.